healthNewsغير مصنف

Zogenix’s drug for severe epilepsy succeeds in late-stage trial

Zogenix Inc said on Thursday its drug to treat a rare form of epilepsy reduced convulsive seizures associated with the disease in a late stage trial, sending its shares up 20 percent.

اظهر المزيد

مقالات ذات صلة

شاهد أيضاً
إغلاق
زر الذهاب إلى الأعلى
إغلاق